Anaut Co., Ltd., developing innovative AI medical devices for surgical care, completes Series B funding to accelerate global expansion

Q: What are the key facts in this article?

Anaut Co., Ltd., a developer of AI medical devices for surgical care, has completed its Series B funding round to accelerate global expansion. Japan Growth Capital Investment Corporation led the round, with undisclosed total funding earmarked for international market penetration, R&D, and new business initiatives.

Q: What is the direct answer?

Anaut Co., Ltd., a developer of AI medical devices for surgical care, has completed its Series B funding round to accelerate global expansion. Japan Growth Capital Investment Corporation led the round, with undisclosed total funding earmarked for international market penetration, R&D, and new business initiatives.

Q: What is the source and date?

Source: https://prtimes.jp/main/html/rd/p/000000017.000063564.html | Date: Date unavailable

Anaut Co., Ltd. (Headquarters: Tokyo; Representative Director: Naoshi Kobayashi (Surgeon) https://anaut-surg.com/), whose mission is "to deliver greater safety and peace of mind than ever before to all patients requiring surgical procedures," has completed a third-party allocation of new shares as part of its Series B funding round. The funds raised in this round will be utilized to further accelerate the rapidly progressing overseas expansion, implement research and development including the launch of new businesses, and promote product dissemination. Challenges surrounding surgical medicine Despite advancements in therapeutic devices such as surgical assistance robots, medical facilities in recent years have faced issues such as a shortage of surgeons, disparities in medical care between regions, and the increasing sophistication and complexity of surgical procedures. Establishing a sustainable medical supply system has become an urgent challenge. Particularly in areas dependent on the expertise of skilled surgeons, there is a demand for standardization of medical quality and advanced education, indicating that technological support for doctors' perceptual domains is indispensable. Furthermore, despite the tremendous efforts of medical professionals, surgical complications in surgical medicine remain a significant challenge. Anaut Co., Ltd.'s initiative: Developing and disseminating Japan-originated surgical assistance AI sought globally To address the aforementioned challenges, Anaut Co., Ltd., spearheaded by surgeon Kobayashi, has been committed to providing perceptual support to operators through AI since 2018, even before its establishment. As a result of these efforts, in 2024, ahead of the world, they obtained manufacturing and marketing approval (Approval No.: 30600BZX00061000) from the Minister of Health, Labour and Welfare on April 12, 2024, for their surgical image recognition support program that provides real-time visual assistance to doctors (Product

Anaut Co., Ltd., developing innovative AI medical devices for surgical care, completes Series B funding to accelerate global expansion

AI Summary (NQ-processed)

AI Analysis